Science Explorer Back to mapMap
Discussion
Company · Cambridge · United States

Eutropics Pharmaceuticals (United States)

eutropics.comROR OpenAlex
Research works
28
▼ 20% vs 2018-21
Citations
496
18.0 per fractional work
Top-10% rate
2.3%
all institutions 10.0%
Open access
25%
world 40%
International
43%
world 18%
Eutropics Pharmaceuticals (United States)

Not ranked overall: Eutropics Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Eutropics Pharmaceuticals (United States) work in?

In all years, 40% of research at Eutropics Pharmaceuticals (United States) is in Physical Sciences, 31% in Life Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (30%), Medicine (25%), Engineering (17%). It does 1.6× the world's share of Life Sciences.

Physical Sciences: 11 fractional works · 39.7% of its workEngineering: 5 fractional works · 16.6% of its workMechanics of Materials: 2 fractional works · 6.8% of its workOcean Engineering: 1 fractional works · 5.2% of its workMechanical Engineering: 1 fractional works · 2.8% of its workComputational Mechanics: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.9% of its workEarth and Planetary Sciences: 4 fractional works · 14.1% of its workGeology: 1 fractional works · 4.2% of its workPaleontology: 1 fractional works · 3.6% of its workEarth-Surface Processes: 1 fractional works · 3.0% of its workGeophysics: 1 fractional works · 2.0% of its workAtmospheric Science: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 1 fractional works · 3.0% of its workNuclear and High Energy Physics: 1 fractional works · 3.0% of its workMaterials Science: 1 fractional works · 2.6% of its workBiomaterials: 1 fractional works · 2.4% of its workMaterials Chemistry: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 2.1% of its workArtificial Intelligence: 1 fractional works · 1.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.7% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.1% of its workLife Sciences: 9 fractional works · 31.4% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 30.0% of its workMolecular Biology: 8 fractional works · 27.8% of its workCancer Research: 0 fractional works · 1.4% of its workGenetics: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 1.1% of its workImmunology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workHealth Sciences: 7 fractional works · 25.4% of its workMedicine: 7 fractional works · 25.4% of its workHematology: 3 fractional works · 9.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.6% of its workOncology: 1 fractional works · 2.8% of its workGenetics: 1 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.2% of its workPathology and Forensic Medicine: 0 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 3.5% of its workDecision Sciences: 0 fractional works · 1.2% of its workManagement Science and Operations Research: 0 fractional works · 1.2% of its workArts and Humanities: 0 fractional works · 0.9% of its workArcheology: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.9% of its workArcheology: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKEutropicsPharmaceuticals…28fractional works, all years
Life Sciences31%Physical Sciences40%Health Sciences25%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Engineering516.6%
    2. Earth and Planetary Sciences414.1%
    3. Physics and Astronomy13.0%
    4. Materials Science12.6%
    5. Computer Science12.1%
    6. Energy00.7%
    7. Chemistry00.6%
    8. Environmental Science00.1%
    1. Biochemistry, Genetics and Molecular Biology830.0%
    2. Immunology and Microbiology01.1%
    3. Agricultural and Biological Sciences00.3%
    1. Medicine725.4%
    1. Decision Sciences01.2%
    2. Arts and Humanities00.9%
    3. Social Sciences00.9%
    4. Economics, Econometrics and Finance00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.55× its world share, 0 worksBiochemistry, Geneti…Computer Science: 0.58× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 13.67× its world share, 1 worksEarth and Planetary …Energy: 4.67× its world share, 0 worksEnergyEngineering: 1.28× its world share, 1 worksEngineeringMedicine: 1.30× its world share, 1 worksMedicineArts and Humanities: 2.03× its world share, 0 worksArts and HumanitiesDecision Sciences: 8.07× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.46× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.46× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Earth and Planetary Sciences, 13.7×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Earth and Planetary Sciences13.67×1 works
  2. Decision Sciences8.07×0 works
  3. Energy4.67×0 works
  4. Arts and Humanities2.03×0 works
  5. Economics, Econometrics and Finance1.46×0 works
  6. Medicine1.30×1 works
  7. Engineering1.28×1 works
  8. Computer Science0.58×0 works
  9. Biochemistry, Genetics and Molecular Biology0.55×0 works
  10. Social Sciences0.46×0 works

Who are the top researchers at Eutropics Pharmaceuticals (United States)?

Ranked on the quality score, Camille E. Doykan, Nicole E. Carlson and Michael H. Cardone lead among researchers whose main affiliation is Eutropics Pharmaceuticals (United States).

  1. 1 Camille E. Doykan United States · #1,190,779 worldwide 4.5k citations · 21 works
  2. 2 Nicole E. Carlson United States · #1,436,946 worldwide 1.3k citations · 21 works
  3. 3 Michael H. Cardone United States · #1,767,786 worldwide 5.5k citations · 91 works
  4. 4 Joanna Garland United States · #2,727,473 worldwide 394 citations · 20 works
  5. 5 Ryan J. Lena United States · #3,097,349 worldwide 369 citations · 49 works
  6. 6 P. Gutteridge United States · #3,544,634 worldwide 529 citations · 34 works
  7. 7 Noel Blake United States · #4,187,839 worldwide 374 citations · 17 works
All ranked researchers at Eutropics Pharmaceuticals (United States)

What are the most cited papers from Eutropics Pharmaceuticals (United States)?

The most cited paper from Eutropics Pharmaceuticals (United States) is "BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies" (James M. Bogenberger et al., 2014), with 199 citations. Next come "Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells" (167) and "Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90" (141).

Most cited papers
#PaperReleasedCitations
1 BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies James M. Bogenberger et al. · Leukemia Open access 23 Jan 2014 199
2 Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells Qun Zhou, Agoston T. Agoston, Peter Wisdom Atadja et al. · Molecular Cancer Research Open access May 2008 167
3 Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90 Warren C. Fiskus, Yuan Ren, Alex Mohapatra et al. · Clinical Cancer Research 15 Aug 2007 141
4 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research 31 Jul 2014 121
5 Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT Neil A. O’Brien, K McDonald, Tong Luo et al. · Clinical Cancer Research 30 May 2014 118
All 51 most cited papers, with filters and sorting

Which keywords describe research at Eutropics Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Prognostic Factors, Hematopoietic Stem Cells, Pore Structure, Shale Gas, Acute Myeloid Leukemia, AML and Apoptosis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cancer Therapy3▲ 17×8 topics
  2. Prognostic Factors2▲ 20×3 topics
  3. Hematopoietic Stem Cells2▲ 68×2 topics
  4. Pore Structure2▲ 63×1 topic
  5. Shale Gas2▲ 52×1 topic
  6. AML2▲ 138×1 topic
  7. Acute Myeloid Leukemia2▲ 138×1 topic
  8. Apoptosis2▲ 15×5 topics
  9. Cancer1▲ 3.6×11 topics
  10. Geophysical Imaging1▲ 65×2 topics
  11. Nanoparticles1▲ 3.5×3 topics
  12. Cancer Progression1▲ 19×2 topics
  13. Continental Margin1▲ 63×2 topics
  14. Crustal Structure1▲ 63×2 topics
  15. Glycosylation1▲ 19×2 topics
  16. Hydrogeology1▲ 106×2 topics
  17. Transcriptional Regulation1▲ 18×3 topics
  18. Bcl-2 Family1▲ 139×1 topic
  19. Cell Death1▲ 20×1 topic
  20. Cenozoic Evolution1▲ 92×1 topic
  21. Ensemble Kalman Filter1▲ 33×1 topic
  22. Fc Receptors1▲ 36×1 topic
  23. Optimization1▲ 7.0×1 topic
  24. Plate Tectonics1▲ 16×1 topic
  25. Porous Media1▲ 23×2 topics
  26. Therapeutic Antibodies1▲ 28×1 topic

Which research topics does Eutropics Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Geological and Geophysical Studies, Hydrocarbon exploration and reservoir analysis, Metallurgy and Cultural Artifacts and Archaeology and Historical Studies.

Geological and Geophysic…0Geological and Geophysical Studies: 0 fractional worksHydrocarbon exploration …0Hydrocarbon exploration and reservoir analysis: 0 fractional worksMetallurgy and Cultural Artifacts: 0 fractional worksArchaeology and Historical Studies: 0 fractional worksReservoir Engineering an…0Reservoir Engineering and Simulation Methods: 0 fractional worksConstruction Project Management and Performance: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksGeological formations and processes: 0 fractional works
GeologyMechanics of MaterialsArcheologyOcean Engineering5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Geological and Geophysical Studies Geology 0 works
  2. 2 Hydrocarbon exploration and reservoir analysis Mechanics of Materials 0 works
  3. 3 Metallurgy and Cultural Artifacts Archeology 0 works
  4. 4 Archaeology and Historical Studies Archeology 0 works
  5. 5 Reservoir Engineering and Simulation Methods Ocean Engineering 0 works
  6. 6 Construction Project Management and Performance Management Science and Operations Research 0 works
  7. 7 Chronic Lymphocytic Leukemia Research Genetics 0 works
  8. 8 Acute Myeloid Leukemia Research Hematology 0 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  10. 10 Geological formations and processes Earth-Surface Processes 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.8%not open75.2%

World: 40% of research is openly available.

with international co-authors42.9%domestic only57.1%

World: 18% is written across borders.

How has Eutropics Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 20% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eutropics Pharmaceuticals (United States) as a percentage of every work published that year, 0.000040% in 2024.

still counting0.00010%0.00020%0.00030%Eutropics Pharmaceuticals (United States)0.000016% in 20251990200020102020

Fractional works of Eutropics Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eutropics Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.